Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Yumanity Therapeutics Q3 EPS $(0.97), Sales $1.64M

Yumanity Therapeutics (NASDAQ:YMTX) reported quarterly losses of $(0.97) per share. The company reported $1.64 million in sales this quarter.
byLuke J Jacobi
November 15, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Yumanity Therapeutics (NASDAQ:YMTX) reported quarterly losses of $(0.97) per share. The company reported $1.64 million in sales this quarter.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Amerco’s Earnings Outlook

By Benzinga Insights
Today, 7:40 AM
Amerco (NASDAQ:UHAL) is set to give its latest quarterly earnings report on Wednesday, 2022-05-25. Here's what investors need to know before the announcement. Analysts estimate that Amerco will report an earnings per share (EPS) of $7.38.

UHAL